Date: 2015-03-02
Type of information: Nomination
Compound:
Company: Macrocure (Israel)
Therapeutic area:
Type agreement: nomination
Action mechanism:
Disease:
Details: * On March 2, 2015, Macrocure, a clinical-stage biopharmaceutical company focused on developing a novel therapeutic platform to address chronic and hard-to-heal wounds, announced that Dr. Ramesh Tharuvai has joined Macrocure as Vice President, Operations effective March 2, 2015. Most recently, Dr. Tharuvai was Vice President, Manufacturing and Product Supply, at Nuron Biotech, a private, clinical stage biopharmaceuticals company. Prior to Nuron, Dr. Tharuvai held senior-level positions at Pfizer and Wyeth within supply chain and operations. For more than 10 years, he was responsible for modeling, redesigning, and improving performance in several global product portfolios as well as establishing the Sales & Operations Planning process for Wyeth\'s Vaccine business and global portfolio. At Pfizer, Dr. Tharuvai had responsibility for the Specialty Care supply chain, which included 22 brands of biologics, vaccines, and small molecules.
Financial terms:
Latest news:
